FULC Overview
Upcoming Projects (FULC)
-
Don’t see a project related to the company you care about? Create your own!
Executed Projects (FULC)
-
A Second View: Looking into the recent decision by Pfizer to remove its sickle cell disease medication OXBRYTA (voxelotor) from the market.
Tickers: PFE, FULC
Executed On: Nov 07, 2024 at 01:00 PM EST -
Looking into the recent decision by Pfizer to remove its sickle cell disease medication OXBRYTA (voxelotor) from the market.
Tickers: PFE, FULC
Executed On: Oct 31, 2024 at 10:00 AM EDT -
A Third Look: Reviewing Avidity Biosciences Phase 1/2 FORTITUDE trial of AOC 1020 (del-brax) demonstrating robust reductions of the DUX4 gene for FSHD management
Tickers: RNA, FULC
Executed On: Aug 30, 2024 at 12:30 PM EDT -
A Second Look: Reviewing Avidity Biosciences Phase 1/2 FORTITUDE trial of AOC 1020 (del-brax) demonstrating robust reductions of the DUX4 gene for FSHD management
Tickers: RNA, FULC
Executed On: Aug 07, 2024 at 02:00 PM EDT -
Reviewing Avidity Biosciences Phase 1/2 FORTITUDE trial of AOC 1020 (del-brax) demonstrating robust reductions of the DUX4 gene for FSHD management
Tickers: RNA, FULC
Executed On: Jul 03, 2024 at 10:00 AM EDT -
The potential of Fulcram's Losmapimod in treating Facioscapulohumeral Muscular Dystrophy (FSHD)
Ticker: FULC
Executed On: Nov 21, 2022 at 03:00 PM EST -
A Third look at the early stage data of FTX-6058 in treating sickle-cell disease
Ticker: FULC
Executed On: Sep 23, 2022 at 12:00 PM EDT -
A Second look at the early stage data of FTX-6058 in treating sickle-cell disease
Ticker: FULC
Executed On: Aug 25, 2022 at 09:00 AM EDT -
A look at FTX-6058 in Sickle Cell Disease
Ticker: FULC
Executed On: Jan 11, 2022 at 04:00 PM EST
Upcoming & Overdue Catalysts (FULC)
-
Don’t see a catalyst related to the company you care about? Create your own!
Strategic Initiatives (FULC)
-
Don’t see a strategic initiative related to the company you care about? Create your own!
